Intuitive Surgical Inc (ISRG) stock
ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3030% above fair value
$430.53−7.22 (-1.65%)
Close on Nov 17, 2026Market cap $149.24BP/E 52.1Yield –
Intuitive Surgical r&d expenses
Research and development expenses are spending on new products and technology.
Intuitive Surgical's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.49B, up 19.2% year over year. For fiscal 2025 it was $1.31B, up 14.5% from the year before. Over ten years it grew 20.9% a year on average. The highest annual figure on record is $1.31B in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.31B | +14.5% |
| FY2024 | Dec 31, 2024 | $1.15B | +14.7% |
| FY2023 | Dec 31, 2023 | $998.80M | +13.6% |
| FY2022 | Dec 31, 2022 | $879.00M | +31.0% |
| FY2021 | Dec 31, 2021 | $671.00M | +12.8% |
| FY2020 | Dec 31, 2020 | $595.10M | +6.8% |
| FY2019 | Dec 31, 2019 | $557.30M | +33.3% |
| FY2018 | Dec 31, 2018 | $418.10M | +27.2% |
| FY2017 | Dec 31, 2017 | $328.60M | +37.1% |
| FY2016 | Dec 31, 2016 | $239.60M | +21.4% |
| FY2015 | Dec 31, 2015 | $197.40M | +10.9% |
| FY2014 | Dec 31, 2014 | $178.00M | +6.1% |
| FY2013 | Dec 31, 2013 | $167.70M | -1.4% |
| FY2012 | Dec 31, 2012 | $170.00M | +21.3% |
| FY2011 | Dec 31, 2011 | $140.20M | +20.9% |
| FY2010 | Dec 31, 2010 | $116.00M | +22.0% |
| FY2009 | Dec 31, 2009 | $95.10M | +19.8% |
| FY2008 | Dec 31, 2008 | $79.40M | +62.5% |
| FY2007 | Dec 31, 2007 | $48.86M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $408.30M | +24.0% |
| Q2 FY2026 | Jun 30, 2026 | $370.60M | +18.3% |
| Q1 FY2026 | Mar 31, 2026 | $361.90M | +14.5% |
| Q4 FY2025 | Dec 31, 2025 | $352.90M | +19.7% |
| Q3 FY2025 | Sep 30, 2025 | $329.40M | +15.2% |
| Q2 FY2025 | Jun 30, 2025 | $313.30M | +11.9% |
| Q1 FY2025 | Mar 31, 2025 | $316.20M | +11.1% |
| Q4 FY2024 | Dec 31, 2024 | $294.70M | +13.3% |
| Q3 FY2024 | Sep 30, 2024 | $286.00M | +14.7% |
| Q2 FY2024 | Jun 30, 2024 | $280.10M | +14.6% |
| Q1 FY2024 | Mar 31, 2024 | $284.50M | +16.2% |
| Q4 FY2023 | Dec 31, 2023 | $260.10M | +6.6% |
| Q3 FY2023 | Sep 30, 2023 | $249.40M | +14.9% |
| Q2 FY2023 | Jun 30, 2023 | $244.40M | +17.9% |
| Q1 FY2023 | Mar 31, 2023 | $244.90M | +16.3% |
| Q4 FY2022 | Dec 31, 2022 | $244.10M | +33.1% |
| Q3 FY2022 | Sep 30, 2022 | $217.10M | +31.2% |
| Q2 FY2022 | Jun 30, 2022 | $207.30M | +27.7% |
| Q1 FY2022 | Mar 31, 2022 | $210.50M | +31.7% |
| Q4 FY2021 | Dec 31, 2021 | $183.40M | +22.4% |
| Q3 FY2021 | Sep 30, 2021 | $165.50M | +6.8% |
| Q2 FY2021 | Jun 30, 2021 | $162.30M | +13.3% |
| Q1 FY2021 | Mar 31, 2021 | $159.80M | +8.6% |
| Q4 FY2020 | Dec 31, 2020 | $149.80M | -4.3% |
| Q3 FY2020 | Sep 30, 2020 | $155.00M | +14.1% |
| Q2 FY2020 | Jun 30, 2020 | $143.20M | +18.5% |
| Q1 FY2020 | Mar 31, 2020 | $147.10M | +2.2% |
| Q4 FY2019 | Dec 31, 2019 | $156.60M | +30.6% |
| Q3 FY2019 | Sep 30, 2019 | $135.90M | +26.3% |
| Q2 FY2019 | Jun 30, 2019 | $120.80M | +27.0% |
| Q1 FY2019 | Mar 31, 2019 | $144.00M | +50.8% |
| Q4 FY2018 | Dec 31, 2018 | $119.90M | +37.7% |
| Q3 FY2018 | Sep 30, 2018 | $107.60M | +29.0% |
| Q2 FY2018 | Jun 30, 2018 | $95.10M | +12.4% |
| Q1 FY2018 | Mar 31, 2018 | $95.50M | +29.9% |
| Q4 FY2017 | Dec 31, 2017 | $87.10M | +26.0% |
| Q3 FY2017 | Sep 30, 2017 | $83.40M | – |
| Q2 FY2017 | Jun 30, 2017 | $84.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $73.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $69.10M | – |
See a number that looks wrong?